1-(1-benzylindazol-4-yl)-3-[(1R)-5-tert-butyl-2,3-dihydro-1H-inden-1-yl]urea;1-(2-benzylindazol-4-yl)-3-[(1R)-5-tert-butyl-2,3-dihydro-1H-inden-1-yl]urea

C56H60N8O2 — CID 162200003

IUPAC1-(1-benzylindazol-4-yl)-3-[(1R)-5-tert-butyl-2,3-dihydro-1H-inden-1-yl]urea;1-(2-benzylindazol-4-yl)-3-[(1R)-5-tert-butyl-2,3-dihydro-1H-inden-1-yl]urea
SMILESCC(C)(C)c1ccc2c(c1)CC[C@H]2NC(=O)Nc1cccc2c1cnn2Cc1ccccc1.CC(C)(C)c1ccc2c(c1)CC[C@H]2NC(=O)Nc1cccc2nn(Cc3ccccc3)cc12
InChIInChI=1S/2C28H30N4O/c1-28(2,3)21-13-14-22-20(16-21)12-15-25(22)31-27(33)30-24-10-7-11-26-23(24)17-29-32(26)18-19-8-5-4-6-9-19;1-28(2,3)21-13-14-22-20(16-21)12-15-25(22)30-27(33)29-24-10-7-11-26-23(24)18-32(31-26)17-19-8-5-4-6-9-19/h4-11,13-14,16-17,25H,12,15,18H2,1-3H3,(H2,30,31,33);4-11,13-14,16,18,25H,12,15,17H2,1-3H3,(H2,29,30,33)/t2*25-/m11/s1
InChIKeyZRLKLAWLAXYMAS-PYZOFXEKSA-N
MW877.15 g/mol
LogP12.38
Rot. Bonds8

About 1-(1-benzylindazol-4-yl)-3-[(1R)-5-tert-butyl-2,3-dihydro-1H-inden-1-yl]urea;1-(2-benzylindazol-4-yl)-3-[(1R)-5-tert-butyl-2,3-dihydro-1H-inden-1-yl]urea

1-(1-benzylindazol-4-yl)-3-[(1R)-5-tert-butyl-2,3-dihydro-1H-inden-1-yl]urea;1-(2-benzylindazol-4-yl)-3-[(1R)-5-tert-butyl-2,3-dihydro-1H-inden-1-yl]urea (PubChem CID 162200003) has the molecular formula C56H60N8O2 and a molecular weight of 877.15 g/mol. Its IUPAC name is 1-(1-benzylindazol-4-yl)-3-[(1R)-5-tert-butyl-2,3-dihydro-1H-inden-1-yl]urea;1-(2-benzylindazol-4-yl)-3-[(1R)-5-tert-butyl-2,3-dihydro-1H-inden-1-yl]urea.

Molecular Properties

Compound Name1-(1-benzylindazol-4-yl)-3-[(1R)-5-tert-butyl-2,3-dihydro-1H-inden-1-yl]urea;1-(2-benzylindazol-4-yl)-3-[(1R)-5-tert-butyl-2,3-dihydro-1H-inden-1-yl]urea
PubChem CID162200003
Molecular FormulaC56H60N8O2
Molecular Weight877.15 g/mol
Exact Mass876.48
IUPAC Name1-(1-benzylindazol-4-yl)-3-[(1R)-5-tert-butyl-2,3-dihydro-1H-inden-1-yl]urea;1-(2-benzylindazol-4-yl)-3-[(1R)-5-tert-butyl-2,3-dihydro-1H-inden-1-yl]urea
SMILESCC(C)(C)c1ccc2c(c1)CC[C@H]2NC(=O)Nc1cccc2c1cnn2Cc1ccccc1.CC(C)(C)c1ccc2c(c1)CC[C@H]2NC(=O)Nc1cccc2nn(Cc3ccccc3)cc12
InChIInChI=1S/2C28H30N4O/c1-28(2,3)21-13-14-22-20(16-21)12-15-25(22)31-27(33)30-24-10-7-11-26-23(24)17-29-32(26)18-19-8-5-4-6-9-19;1-28(2,3)21-13-14-22-20(16-21)12-15-25(22)30-27(33)29-24-10-7-11-26-23(24)18-32(31-26)17-19-8-5-4-6-9-19/h4-11,13-14,16-17,25H,12,15,18H2,1-3H3,(H2,30,31,33);4-11,13-14,16,18,25H,12,15,17H2,1-3H3,(H2,29,30,33)/t2*25-/m11/s1
InChIKeyZRLKLAWLAXYMAS-PYZOFXEKSA-N
XLogP12.38
TPSA117.90 Ų
H-Bond Donors4
H-Bond Acceptors6
Rotatable Bonds8
Heavy Atoms66
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500877.15
LogP ≤ 512.38
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 106

Analyze 1-(1-benzylindazol-4-yl)-3-[(1R)-5-tert-butyl-2,3-dihydro-1H-inden-1-yl]urea;1-(2-benzylindazol-4-yl)-3-[(1R)-5-tert-butyl-2,3-dihydro-1H-inden-1-yl]urea with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 1-(1-benzylindazol-4-yl)-3-[(1R)-5-tert-butyl-2,3-dihydro-1H-inden-1-yl]urea;1-(2-benzylindazol-4-yl)-3-[(1R)-5-tert-butyl-2,3-dihydro-1H-inden-1-yl]urea?
The IUPAC name of 1-(1-benzylindazol-4-yl)-3-[(1R)-5-tert-butyl-2,3-dihydro-1H-inden-1-yl]urea;1-(2-benzylindazol-4-yl)-3-[(1R)-5-tert-butyl-2,3-dihydro-1H-inden-1-yl]urea (CID 162200003) is 1-(1-benzylindazol-4-yl)-3-[(1R)-5-tert-butyl-2,3-dihydro-1H-inden-1-yl]urea;1-(2-benzylindazol-4-yl)-3-[(1R)-5-tert-butyl-2,3-dihydro-1H-inden-1-yl]urea.
What is the SMILES notation for 1-(1-benzylindazol-4-yl)-3-[(1R)-5-tert-butyl-2,3-dihydro-1H-inden-1-yl]urea;1-(2-benzylindazol-4-yl)-3-[(1R)-5-tert-butyl-2,3-dihydro-1H-inden-1-yl]urea?
The canonical SMILES for 1-(1-benzylindazol-4-yl)-3-[(1R)-5-tert-butyl-2,3-dihydro-1H-inden-1-yl]urea;1-(2-benzylindazol-4-yl)-3-[(1R)-5-tert-butyl-2,3-dihydro-1H-inden-1-yl]urea is CC(C)(C)c1ccc2c(c1)CC[C@H]2NC(=O)Nc1cccc2c1cnn2Cc1ccccc1.CC(C)(C)c1ccc2c(c1)CC[C@H]2NC(=O)Nc1cccc2nn(Cc3ccccc3)cc12.
What is the InChIKey of 1-(1-benzylindazol-4-yl)-3-[(1R)-5-tert-butyl-2,3-dihydro-1H-inden-1-yl]urea;1-(2-benzylindazol-4-yl)-3-[(1R)-5-tert-butyl-2,3-dihydro-1H-inden-1-yl]urea?
The InChIKey is ZRLKLAWLAXYMAS-PYZOFXEKSA-N. The full InChI is InChI=1S/2C28H30N4O/c1-28(2,3)21-13-14-22-20(16-21)12-15-25(22)31-27(33)30-24-10-7-11-26-23(24)17-29-32(26)18-19-8-5-4-6-9-19;1-28(2,3)21-13-14-22-20(16-21)12-15-25(22)30-27(33)29-24-10-7-11-26-23(24)18-32(31-26)17-19-8-5-4-6-9-19/h4-11,13-14,16-17,25H,12,15,18H2,1-3H3,(H2,30,31,33);4-11,13-14,16,18,25H,12,15,17H2,1-3H3,(H2,29,30,33)/t2*25-/m11/s1.
What are the key properties of 1-(1-benzylindazol-4-yl)-3-[(1R)-5-tert-butyl-2,3-dihydro-1H-inden-1-yl]urea;1-(2-benzylindazol-4-yl)-3-[(1R)-5-tert-butyl-2,3-dihydro-1H-inden-1-yl]urea?
1-(1-benzylindazol-4-yl)-3-[(1R)-5-tert-butyl-2,3-dihydro-1H-inden-1-yl]urea;1-(2-benzylindazol-4-yl)-3-[(1R)-5-tert-butyl-2,3-dihydro-1H-inden-1-yl]urea has a molecular weight of 877.15 g/mol, XLogP of 12.38, 8 rotatable bonds, 4 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 1-(1-benzylindazol-4-yl)-3-[(1R)-5-tert-butyl-2,3-dihydro-1H-inden-1-yl]urea;1-(2-benzylindazol-4-yl)-3-[(1R)-5-tert-butyl-2,3-dihydro-1H-inden-1-yl]urea is sourced from PubChem (CID 162200003), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).